Welcome to the e-workshop: GenoMed4All – A meeting with Myelodysplastic Syndromes, Multiple Myeloma and Sickle Cell Disease associations

The aim of this meeting is to provide an overview of GenoMed4All’s mission, clinical pilots and relevant AI use-case applications to representatives of major patients’ associations in Europe covering Myelodysplastic SyndromesMultiple Myeloma and Sickle Cell Disease, the 3 clinical areas related to the project. The meeting is organised by the GenoMed4All consortium, in collaboration with ERN-EuroBloodNet.

Speakers will present the cutting-edge advances in Artificial Intelligence (AI) for the diagnosis, treatment and follow up of those rare haematological domains, underlining the increasing role of AI in improving and accelerating patient access to personalized medicine. At the end of the presentations, an open discussion will follow to gather patients’ representatives’ feedback, and discuss their issues, needs and expectations in view of increasingly involving patients’ advocates in the development of clinical AI tools.

For the full agenda, check out the official leaflet below.